We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

46 hedge funds and large institutions have $28.1M invested in Redhill Biopharma in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

180% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 5

10% more funds holding

Funds holding: 42 → 46 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

29% less capital invested

Capital invested by funds: $39.4M → $28.1M (-$11.2M)

47% less call options, than puts

Call options by funds: $57K | Put options by funds: $107K

Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
14
Reduced
5
Closed
3
Calls
$57K
Puts
$107K
Net Calls
-$50K
Net Calls Change
-$145K

Top Buyers

Rank Fund Capital Flow
1
MIFH
Migdal Insurance & Financial Holdings
Israel
+$2.5M
2
SSA
Schonfeld Strategic Advisors
New York
+$540K
3
II
Ibex Investors
Colorado
+$485K
4
PF
Phoenix Financial
Israel
+$430K
5
SFS
Sowell Financial Services
Arkansas
+$265K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$6.28M
2
DGI
Disciplined Growth Investors
Minnesota
-$740K
3
KC
Kepos Capital
New York
-$656K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$200K
5
Morgan Stanley
Morgan Stanley
New York
-$105K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$82K +$90.1K +18 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$76K – – –
MIH
28
Meitav Investment House
Israel
$57K +$65K +13 New
CIBC Private Wealth Group
29
CIBC Private Wealth Group
Georgia
$54K +$60K +12 New
Barclays
30
Barclays
United Kingdom
$51K +$55K +11 New
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$51K +$55K +11 New
VanEck Associates
32
VanEck Associates
New York
$50K – – –
DADC
33
D.A. Davidson & Co
Montana
$50K +$55K +11 New
FDCDDQ
34
Federation des caisses Desjardins du Quebec
Quebec, Canada
$32.7K – – –
Morgan Stanley
35
Morgan Stanley
New York
$22K -$105K -21 -81%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$19K +$5K +1 +33%
Bank of America
37
Bank of America
North Carolina
$14K – – –
CG
38
Cutler Group
California
$11K – – –
UBS Group
39
UBS Group
Switzerland
$11K – – –
WFMPM
40
Woodley Farra Manion Portfolio Management
Indiana
$10K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$10K +$10K +2 New
FANJ
42
Financial Architects (New Jersey)
New Jersey
$9K – – –
KPW
43
Kore Private Wealth
New York
$5K – – –
Wells Fargo
44
Wells Fargo
California
$4K – – –
CP
45
Corbenic Partners
Pennsylvania
$2K – – –
PVH
46
Psagot Value Holdings
Israel
$2K – – –
SPIA
47
Steward Partners Investment Advisory
New York
$2K – – –
IA
48
IFP Advisors
Florida
$1K – – –
6CM
49
683 Capital Management
New York
– -$6.28M -1,035 Closed
KC
50
Kepos Capital
New York
– -$656K -108 Closed
1
2
3

RDHL Hedge Fund Activity: Q1 2020 in Review

46 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q1 2020, worth a combined $28.1M — down 29% from $39.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new RDHL positions and 3 closed out — a net gain of 7 holders — while 14 added to existing stakes and 5 trimmed.

The largest buyer was Migdal Insurance & Financial Holdings, adding an estimated $2.5M. The largest seller was 683 Capital Management, exiting entirely with an estimated $6.28M sold.

  • 46 institutional investors held Redhill Biopharma (RDHL) as of Q1 2020, up from 42 in Q4 2019.
  • Funds reported $28.1M of Redhill Biopharma stock for Q1 2020, down 29% quarter-over-quarter.
  • 10 funds opened new Redhill Biopharma positions in Q1 2020 and 3 closed out, a net change of +7 holders.
  • The largest Redhill Biopharma buyer in Q1 2020 was Migdal Insurance & Financial Holdings, an estimated $2.5M added.
  • The largest Redhill Biopharma seller in Q1 2020 was 683 Capital Management, an estimated $6.28M sold.

Based on aggregated 13F filings for Q1 2020.